Report ID |
35768 |
Drug Identification Number |
02212277 |
Brand name |
CEFTIN - TAB 250MG |
Common or Proper name |
cefuroxime axetil tablets |
Company Name |
GLAXOSMITHKLINE INC |
Market Status |
CANCELLED POST MARKET |
Active Ingredient(s) |
CEFUROXIME |
Strength(s) |
250MG |
Dosage form(s) |
TABLET |
Route of administration |
ORAL |
Packaging size |
60's |
ATC code |
J01DC |
ATC description |
OTHER BETA-LACTAM ANTIBACTERIALS |
Reason for shortage |
Disruption of the manufacture of the drug. |
Anticipated start date |
|
Actual start date |
2018-01-11 |
Estimated end date |
Unknown |
Actual end date |
2020-07-20 |
Shortage status |
Resolved |
Updated date |
2020-07-24 |
Company comments |
product has been discontinued. |
Health Canada comments |
|
Tier 3 Status |
No |
Company contact information |
1-800-387-7374 |